Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Trial of Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance (The SWAT-BE Study)

NCT05530343 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT05530343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05530343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Trial of Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance (The SWAT-BE Study)
Lead sponsor
University of Colorado, Denver
Phase
Not applicable
Overall status
Recruiting
Start date
October 3, 2022
Completion date
June 30, 2026
Enrollment
2,298 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus, barretts esophagus with dysplasia, esophageal adenocarcinoma